Suri 2019.
| Methods | Single‐centre, randomised controlled trial conducted in India |
| Participants |
Inclusion criteria: infants ≥ 37 weeks' gestation; postnatal age > 24 hours to ≤ 10 days and unconjugated bilirubin 12 to 20 mg/dL; APGAR > 6 at 5 minutes Exclusion criteria: infants requiring intensive care ((quote:) "i.e. ventilator, endotracheal intubation, and peritoneal dialysis"); major congenital malformation ((quote:) "cardiac, skeletal, renal, dysmorphism etc"); sepsis ((quote:) "i.e. positive blood culture, fits, reluctance to feed, platelets < 50000"); (quote:) "congenital abnormalities"; (quote:) "Mothers those who are not willing" |
| Interventions | Total N variably reported (N = 100; N = 258) Group A (n variably reported (n = 50; n = 129)): continuous phototherapy (2 hours on, 20 minutes off) Group B (n variably reported (n = 50; n = 129)): intermittent phototherapy (1 hour on, 30 minutes off) Duration of phototherapy and criteria for stopping not specified |
| Outcomes |
Primary outcome
|
| Notes | Reported results identical to Khaliq 2016 (awaiting response from respective authors and editors) |
AAP: American Academy of Pediatrics DCT: Direct Coombs Test G6PD: glucose‐6‐phosphate dehydrogenase Rh: rhesus TSB: total serum bilirubin